S. K. Sullivan

发表

Scintillation Proximity Assay as a High-Throughput Method to Identify Slowly Dissociating Nonpeptide Ligand Binding to the GnRH Receptor

C. Heise, P. Crowe, S. K. Sullivan, 2007, Journal of biomolecular screening.

Selection, synthesis, and structure-activity relationship of tetrahydropyrido[4,3-d]pyrimidine-2,4-diones as human GnRH receptor antagonists.

C. J. Loweth, M. Feher, D. Slee, 2007, Bioorganic & medicinal chemistry.

Pharmacological characterization of a novel nonpeptide antagonist of the human gonadotropin-releasing hormone receptor, NBI-42902.

N. Ling, R. Maki, T. Kohout, 2007, Endocrinology.

Kinetics of nonpeptide antagonist binding to the human gonadotropin-releasing hormone receptor: Implications for structure-activity relationships and insurmountable antagonism.

S. Hoare, Beth A. Fleck, C. Heise, 2006, Biochemical pharmacology.

Conformational states of the corticotropin releasing factor 1 (CRF1) receptor: detection, and pharmacological evaluation by peptide ligands

N. Ling, D. Grigoriadis, S. Hoare, 2003, Peptides.

Structure-activity relationships of 1,3,5-triazine-2,4,6-triones as human gonadotropin-releasing hormone receptor antagonists.

Zhiqian Guo, Chen Chen, S. K. Sullivan, 2005, Bioorganic & medicinal chemistry letters.

Molecular Determinants of Receptor Binding and Signaling by the CX3C Chemokine Fractalkine* 210

T. Schwartz, T. Handel, D. King, 2001, The Journal of Biological Chemistry.

FTY720, a novel transplantation drug, modulates lymphocyte migratory responses to chemokines.

Z. Pan, V. Brinkmann, K. Bacon, 2001, Transplantation proceedings.

Pharmacological and signaling analysis of human chemokine receptor CCR-7 stably expressed in HEK-293 cells: high-affinity binding of recombinant ligands MIP-3beta and SLC stimulates multiple signaling cascades.

D. A. McGrath, D. Grigoriadis, K. Bacon, 1999, Biochemical and biophysical research communications.

Activation of mitogen-activated protein kinase regulates eotaxin-induced eosinophil migration.

K. Bacon, P. Crowe, S. K. Sullivan, 1999, Journal of immunology.

Human thymocytes express CCR-3 and are activated by eotaxin.

N. Taylor, T. Schall, K. Franz-Bacon, 1999, Blood.

Peptide ligand binding properties of the corticotropin-releasing factor (CRF) type 2 receptor: pharmacology of endogenously expressed receptors, G-protein-coupling sensitivity and determinants of CRF2 receptor selectivity

D. Grigoriadis, S. Hoare, Jun Fan, 2005, Peptides.

Characterization of the Interaction of Indiplon, a Novel Pyrazolopyrimidine Sedative-Hypnotic, with the GABAA Receptor

D. Grigoriadis, A. Foster, S. K. Sullivan, 2004, Journal of Pharmacology and Experimental Therapeutics.

Synthesis and structure-activity relationships of uracil derived human GnRH receptor antagonists: (R)-3-[2-(2-amino)phenethyl]-1-(2,6-difluorobenzyl)-6-methyluracils containing a substituted thiophene or thiazole at C-5.

Zhiqian Guo, Chen Chen, S. K. Sullivan, 2004, Bioorganic & medicinal chemistry letters.

Mechanism of corticotropin-releasing factor type I receptor regulation by nonpeptide antagonists.

N. Ling, D. Grigoriadis, S. Hoare, 2003, Molecular Pharmacology.

MIP‐3α induces human eosinophil migration and activation of the mitogen‐activated protein kinases (p42/p44 MAPK)

J. Farber, K. Bacon, S. K. Sullivan, 1999, Journal of leukocyte biology.

Ligand affinity for amino-terminal and juxtamembrane domains of the corticotropin releasing factor type I receptor: regulation by G-protein and nonpeptide antagonists.

N. Ling, W. Vale, D. Grigoriadis, 2004, Biochemistry.